Feng Cheng Li
Orcid: 0000-0002-1846-639X
According to our database1,
Feng Cheng Li
authored at least 18 papers
between 2020 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2023
Nucleic Acids Res., January, 2023
Nucleic Acids Res., January, 2023
Nucleic Acids Res., January, 2023
2022
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents.
Nucleic Acids Res., 2022
Nucleic Acids Res., 2022
PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods.
Comput. Biol. Medicine, 2022
RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection.
Briefings Bioinform., 2022
POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability.
Briefings Bioinform., 2022
Briefings Bioinform., 2022
2021
Nucleic Acids Res., 2021
2020
Nucleic Acids Res., 2020
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data.
Nucleic Acids Res., 2020
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.
Nucleic Acids Res., 2020
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Briefings Bioinform., 2020